TP53 and neoplasm: Proliferation in HT1080 cells is mediated through a NFKB dependent pathways [29,54].Tumor invasiveness could be significantly reduced in HT1080 cells by reducing NFKB activity [30].Increased NFKB activity leads to doxorubicin resistance in a p53 dependent manner [28].